September 24, 2022
Loading...
You are here:  Home  >  Banking & Finance  >  Current Article

Amgen braces for biosimilars rules

IN THIS ARTICLE

The U.S. Food and Drug Administration is set to release guidelines for biosimilar drugs by year’s end. The shape of those guidelines will determine whether the new drugs are a competitive threat or a potential market opportunity for Amgen, the world’s largest biotechnology firm and the biggest private-sector employer in Ventura County. Biosimilars are the…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.